| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Uterine Cervical Neoplasms | D002583 | 10 associated lipids |
| Neoplasms, Experimental | D009374 | 10 associated lipids |
| Neoplasms, Radiation-Induced | D009381 | 3 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Carcinoma, Squamous Cell | D002294 | 14 associated lipids |
| Skin Neoplasms | D012878 | 12 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
hypericin
hypericin is a lipid of Polyketides (PK) class. Hypericin is associated with abnormalities such as Dermatitis, Phototoxic, Dehydration, Photosensitization, Morphologically altered structure and Myocardial Infarction. The involved functions are known as Cell Cycle Checkpoints, Apoptosis, Acetylation, Cell Survival and Caspase Activation. Hypericin often locates in insoluble fraction, Cytoplasmic matrix, Protoplasm, Tissue membrane and Cytoplasm. The associated genes with hypericin are CDC37 gene, HSPA8 gene, RAF1 gene, cyclin H and FK228. The related lipids are Phosphatidylserines.
Cross Reference
Introduction
To understand associated biological information of hypericin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with hypericin?
hypericin is suspected in Dermatitis, Phototoxic, Photosensitization, Pneumonia, Psoriasis, Phototoxicity, Chronic infectious disease and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with hypericin
PubChem Associated disorders and diseases
What pathways are associated with hypericin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with hypericin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with hypericin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with hypericin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with hypericin?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with hypericin?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with hypericin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ni G et al. | The possible use of hypericin to overcome drug resistance in cancer treatment. | 2011 | Chem. Biol. Interact. | pmid:21168397 |
| Tuna G et al. | Inhibition characteristics of hypericin on rat small intestine glutathione-S-transferases. | 2010 | Chem. Biol. Interact. | pmid:20637187 |
| Moulharat N et al. | Molecular pharmacology of adipocyte-secreted autotaxin. | 2008 | Chem. Biol. Interact. | pmid:18282564 |
| Chong K et al. | Enhancement of the photocytotoxic efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria. | 2013 | Chem. Commun. (Camb.) | pmid:24064984 |
| Minnes R et al. | The effect of solution electrolytes on the uptake of photosensitizers by liposomal membranes: a salting-out effect. | 2008 | Chem. Phys. Lipids | pmid:18606157 |
| Huang LF et al. | Hypericin: chemical synthesis and biosynthesis. | 2014 | Chin J Nat Med | pmid:24636057 |
| Li S et al. | Chemical markers for the quality control of herbal medicines: an overview. | 2008 | Chin Med | pmid:18588699 |
| Ciogli A et al. | Determination of enantiomerization barriers of hypericin and pseudohypericin by dynamic high-performance liquid chromatography on immobilized polysaccharide-type chiral stationary phases and off-column racemization experiments. | 2010 | Chirality | pmid:19644936 |
| Halaburková A et al. | Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of . | 2017 | Clin Epigenetics | pmid:28603560 |
| Wurglics M and Schubert-Zsilavecz M | Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients. | 2006 | Clin Pharmacokinet | pmid:16640452 |
| Zhang W et al. | Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro. | 1996 | Clin. Cancer Res. | pmid:9816239 |
| Schroeder C et al. | Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans. | 2004 | Clin. Pharmacol. Ther. | pmid:15536462 |
| Canning S et al. | The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. | 2010 | CNS Drugs | pmid:20155996 |
| Weberschock T et al. | Interventions for mycosis fungoides. | 2012 | Cochrane Database Syst Rev | pmid:22972128 |
| Kuhn D | Hypericin: an answer for safer blood? | 1995 | Common Factor | pmid:11362353 |
| Fonge H et al. | Evaluation of tumor affinity of mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumor. | 2007 May-Jun | Contrast Media Mol Imaging | pmid:17546702 |
| Skyba M et al. | Physiological, biochemical and molecular characteristics of cryopreserved Hypericum perforatum L. shoot tips. | Cryo Letters | pmid:20919454 | |
| Olivo M et al. | Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy. | 2006 | Curr Clin Pharmacol | pmid:18666746 |
| Miskovsky P | Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. | 2002 | Curr Drug Targets | pmid:11899265 |
| Hird AE et al. | Radiation recall dermatitis: case report and review of the literature. | 2008 | Curr Oncol | pmid:18317586 |
| Joudi FN and Konety BR | Fluorescence cystoscopy and bladder surveillance. | 2004 | Curr Opin Urol | pmid:15300146 |
| van den Berg NS et al. | Fluorescence guidance in urologic surgery. | 2012 | Curr Opin Urol | pmid:22262249 |
| Spiess PE and Grossman HB | Fluorescence cystoscopy: is it ready for use in routine clinical practice? | 2006 | Curr Opin Urol | pmid:16905985 |
| Schmidbauer J and Marberger M | Recent developments in fluorescence cystoscopy: do novel agents bring a benefit? | 2007 | Curr Opin Urol | pmid:17762629 |
| Fricker G | Drug interactions with natural products at the blood brain barrier. | 2008 | Curr. Drug Metab. | pmid:19075618 |
| Kober M et al. | Molecular mechanisms underlying St. John's wort drug interactions. | 2008 | Curr. Drug Metab. | pmid:19075619 |
| Hu ZP et al. | A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort. | 2007 | Curr. Drug Metab. | pmid:17305494 |
| Caccia S | Antidepressant-like components of Hypericum perforatum extracts: an overview of their pharmacokinetics and metabolism. | 2005 | Curr. Drug Metab. | pmid:16379667 |
| Weinberger D et al. | Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT. | 2005 | Curr. Eye Res. | pmid:16020257 |
| Harris MS et al. | Hypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of protein kinase C. | 1996 | Curr. Eye Res. | pmid:8654105 |
| Kimura H et al. | Hypericin inhibits choroidal endothelial cell proliferation and cord formation in vitro. | 1997 | Curr. Eye Res. | pmid:9330847 |
| Tahara YR et al. | The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy. | 1999 | Curr. Eye Res. | pmid:10520228 |
| Sgarbossa A et al. | The uptake, location and fluorescence of hypericin in bovine intact lens. | 2000 | Curr. Eye Res. | pmid:11148595 |
| Booth JN and McGwin G | The association between self-reported cataracts and St. John's Wort. | 2009 | Curr. Eye Res. | pmid:19895314 |
| Kiesslich T et al. | Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. | 2006 | Curr. Med. Chem. | pmid:16918348 |
| Krammer B and Verwanger T | Molecular response to hypericin-induced photodamage. | 2012 | Curr. Med. Chem. | pmid:22214453 |
| Kubin A et al. | Hypericin--the facts about a controversial agent. | 2005 | Curr. Pharm. Des. | pmid:15638760 |
| Chen E et al. | One-pot method to prepare a theranostic nanosystem with magnetic resonance imaging function and anticancer activity through multiple mechanisms. | 2017 | Dalton Trans | pmid:28280824 |
| Cona MM et al. | Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction. | 2015 | Drug Deliv | pmid:24417698 |
| Shah AK et al. | Content analysis and stability evaluation of selected commercial preparations of St. John's wort. | 2005 | Drug Dev Ind Pharm | pmid:16306003 |
| Li Y et al. | Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles. | 2016 | Drug Dev Ind Pharm | pmid:26472259 |
| Bergonzi MC et al. | Variability in the content of the constituents of Hypericum perforatum L. and some commercial extracts. | 2001 | Drug Dev Ind Pharm | pmid:11548855 |
| Komoroski BJ et al. | Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. | 2004 | Drug Metab. Dispos. | pmid:15100173 |
| Tian R et al. | Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. | 2005 | Drug Metab. Dispos. | pmid:15640377 |
| Ekins S and Erickson JA | A pharmacophore for human pregnane X receptor ligands. | 2002 | Drug Metab. Dispos. | pmid:11744617 |
| Wada A et al. | Effects of St John's wort and hypericin on cytotoxicity of anticancer drugs. | 2002 | Drug Metab. Pharmacokinet. | pmid:15618698 |
| Mannel M | Drug interactions with St John's wort : mechanisms and clinical implications. | 2004 | Drug Saf | pmid:15350151 |
| Bouron A and Lorrain E | [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature]. | 2014 | Encephale | pmid:23816060 |
| Laffers W et al. | Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro. | 2015 | Eur Arch Otorhinolaryngol | pmid:24687800 |
| Sobaci G et al. | Hypericin-enhanced argon laser photocoagulation for subfoveal choroidal neovascular membrane in age-related macular degeneration: a pilot study. | 2006 Jan-Feb | Eur J Ophthalmol | pmid:16496255 |
| Huygens A et al. | Stability of different formulations and ion pairs of hypericin. | 2005 | Eur J Pharm Biopharm | pmid:15760726 |
| Kamuhabwa AA et al. | Determination of hypericin in human plasma by high-performance liquid chromatography after intravesical administration in patients with transitional cell carcinoma of the bladder. | 2005 | Eur J Pharm Biopharm | pmid:15760727 |
| Hostanska K et al. | Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. | 2003 | Eur J Pharm Biopharm | pmid:12837490 |
| Duan X et al. | Radioiodinated hypericin disulfonic acid sodium salts as a DNA-binding probe for early imaging of necrotic myocardium. | 2017 | Eur J Pharm Biopharm | pmid:28414189 |
| Zeisser-Labouèbe M et al. | Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases. | 2009 | Eur J Pharm Biopharm | pmid:18977296 |
| Ritz R et al. | Hypericin for visualization of high grade gliomas: first clinical experience. | 2012 | Eur J Surg Oncol | pmid:22284346 |
| Langosch JM et al. | St John's wort (Hypericum perforatum) modulates evoked potentials in guinea pig hippocampal slices via AMPA and GABA receptors. | 2002 | Eur Neuropsychopharmacol | pmid:12007672 |
| Ocak Z et al. | Effect of hypericin on the ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells. | 2013 | Eur Rev Med Pharmacol Sci | pmid:23690187 |
| Bramanti E et al. | Effects of hypericin on the structure and aggregation properties of β-amyloid peptides. | 2010 | Eur. Biophys. J. | pmid:20473492 |
| Fonge H et al. | Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT. | 2008 | Eur. Heart J. | pmid:18156139 |
| Johne A et al. | Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers. | 2004 | Eur. J. Clin. Pharmacol. | pmid:15372129 |
| Mueller SC et al. | The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. | 2006 | Eur. J. Clin. Pharmacol. | pmid:16341856 |
| Golestani R et al. | Small-animal SPECT and SPECT/CT: application in cardiovascular research. | 2010 | Eur. J. Nucl. Med. Mol. Imaging | pmid:20069298 |
| Ni Y et al. | First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent. | 2006 | Eur. J. Nucl. Med. Mol. Imaging | pmid:16450141 |
| Simmen U et al. | Antagonist effect of pseudohypericin at CRF1 receptors. | 2003 | Eur. J. Pharmacol. | pmid:12504780 |
| MartÃnez-Poveda B et al. | Hypericin in the dark inhibits key steps of angiogenesis in vitro. | 2005 | Eur. J. Pharmacol. | pmid:15921677 |
| Chang Y and Wang SJ | Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway. | 2010 | Eur. J. Pharmacol. | pmid:20193678 |
| Wang Y et al. | Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead. | 2007 | Eur. J. Pharmacol. | pmid:17116302 |
| Jocham D et al. | Photodynamic diagnosis in urology: state-of-the-art. | 2008 | Eur. Urol. | pmid:18096307 |
| D'Hallewin MA et al. | Fluorescence detection of bladder cancer: a review. | 2002 | Eur. Urol. | pmid:12429148 |
| Cooper EL | Stem cells and CAM. | 2006 | Evid Based Complement Alternat Med | pmid:16786045 |
| Rozanova Torshina N et al. | Catalytic therapy of cancer with ascorbate and extracts of medicinal herbs. | 2010 | Evid Based Complement Alternat Med | pmid:18955293 |
| Calapai G and Caputi AP | Herbal medicines: can we do without pharmacologist? | 2007 | Evid Based Complement Alternat Med | pmid:18227932 |
| Li Y et al. | Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic 131I-hypericin in rat models. | 2015 | Exp. Biol. Med. (Maywood) | pmid:25956680 |
| Cona MM et al. | Improved clearance of radioiodinated hypericin as a targeted anticancer agent by using a duodenal drainage catheter in rats. | 2013 | Exp. Biol. Med. (Maywood) | pmid:24146264 |
| Cohen PA et al. | Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens. | 1996 | Experientia | pmid:8608821 |
| Pietta P et al. | Comparative evaluation of St. John's wort from different Italian regions. | 2001 May-Jul | Farmaco | pmid:11482784 |
| Buytaert E et al. | Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. | 2006 | FASEB J. | pmid:16455754 |
| Romerio F and Zella D | MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. | 2002 | FASEB J. | pmid:12206994 |
| Karppinen K et al. | Octaketide-producing type III polyketide synthase from Hypericum perforatum is expressed in dark glands accumulating hypericins. | 2008 | FEBS J. | pmid:18647343 |
| Chaloupka R et al. | Over-expression of Bcl-2 does not protect cells from hypericin photo-induced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway. | 1999 | FEBS Lett. | pmid:10622714 |
| Sgarbossa A et al. | In vitro perturbation of aggregation processes in beta-amyloid peptides: a spectroscopic study. | 2008 | FEBS Lett. | pmid:18805418 |
| Vantieghem A et al. | Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. | 1998 | FEBS Lett. | pmid:9862416 |
| Varriale L et al. | Molecular aspects of photodynamic therapy: low energy pre-sensitization of hypericin-loaded human endometrial carcinoma cells enhances photo-tolerance, alters gene expression and affects the cell cycle. | 2002 | FEBS Lett. | pmid:11852097 |
| Schempp CM et al. | Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. | 2001 | FEBS Lett. | pmid:11277999 |
| Song X et al. | [The development of secondary cells in the callus of Hypericum perforatum L. and hypericins accumulation]. | 2007 | Fen Zi Xi Bao Sheng Wu Xue Bao | pmid:17357449 |
| Chan LY et al. | A study of hypericin-induced teratogenicity during organogenesis using a whole rat embryo culture model. | 2001 | Fertil. Steril. | pmid:11704142 |
| Tirillini B et al. | Induction of hypericins in Hypericum perforatum in response to chromium. | 2006 | Fitoterapia | pmid:16554124 |
| Filippini R et al. | Study of dynamic accumulation of secondary metabolites in three subspecies of Hypericum perforatum. | 2010 | Fitoterapia | pmid:19686808 |
| Galeotti N et al. | St. John's Wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes. | 2014 | Fitoterapia | pmid:24125916 |
| Conforti F et al. | Antioxidant activity of methanolic extract of Hypericum triquetrifolium Turra aerial part. | 2002 | Fitoterapia | pmid:12385870 |
| Saczko J et al. | Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of Photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma. | 2007 | Folia Histochem. Cytobiol. | pmid:17597022 |
| Diwu Z and Lown JW | Photosensitization with anticancer agents. 17. EPR studies of photodynamic action of hypericin: formation of semiquinone radical and activated oxygen species on illumination. | 1993 | Free Radic. Biol. Med. | pmid:8381107 |
| Rubio N et al. | p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling. | 2014 | Free Radic. Biol. Med. | pmid:24269898 |
| Johnson SA et al. | Time-course of hypericin phototoxicity and effect on mitochondrial energies in EMT6 mouse mammary carcinoma cells. | 1998 | Free Radic. Biol. Med. | pmid:9667489 |
| Johnson SA and Pardini RS | Antioxidant enzyme response to hypericin in EMT6 mouse mammary carcinoma cells. | 1998 | Free Radic. Biol. Med. | pmid:9586812 |
| Theodossiou TA et al. | Molecular modeling and experimental evidence for hypericin as a substrate for mitochondrial complex III; mitochondrial photodamage as demonstrated using specific inhibitors. | 2008 | Free Radic. Biol. Med. | pmid:18852042 |
| Ehrenshaft M et al. | Hypericin-mediated photooxidative damage of α-crystallin in human lens epithelial cells. | 2013 | Free Radic. Biol. Med. | pmid:23453985 |
| Laggner H et al. | Hypericin and photodynamic treatment do not interfere with transport of vitamin C during respiratory burst. | 2004 | Free Radic. Res. | pmid:15512795 |
| Laggner H et al. | The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug? | 2007 | Free Radic. Res. | pmid:17364950 |